The American Journal of Medicine
Volume 122, Issue 2 , Pages 144-151 , February 2009

Predictors and Implications of Q-Waves in ST-Elevation Acute Coronary Syndromes

  • Troy LaBounty, MD

      Affiliations

    • Weill Cornell Medical College, New York, NY
    • ,
  • Hitinder S. Gurm, MD

      Affiliations

    • University of Michigan, Ann Arbor, Mich
    • Ann Arbor Veterans Administration Hospital, Ann Arbor, Mich
    • ,
  • Shaun G. Goodman, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Gilles Montalescot, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France
    • ,
  • Jose Lopez-Sendon, MD

      Affiliations

    • Hospital Universitario La Paz, Madrid, Spain
    • ,
  • Ann Quill, MA

      Affiliations

    • University of Massachusetts, Worcester
    • ,
  • Kim A. Eagle, MD

      Affiliations

    • University of Michigan, Ann Arbor, Mich
    • Corresponding Author InformationRequests for reprints should be addressed to Kim A Eagle, MD, Cardiovascular Center, University of Michigan, 1500 East Medical Center Drive, Room 2135-B, Ann Arbor, MI 48109-5852
    • ,
  • GRACE Investigators

References 

  1. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–2653
  2. Schinkel AF, Bax JJ, Elhendy A, et al. Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy. Am J Cardiol. 2002;89:1171–1175
  3. Moon JC, De Arenaza DP, Elkington AG, et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol. 2004;44:554–560
  4. Kaandorp TA, Bax JJ, Lamb HJ, et al. Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?. Am J Cardiol. 2005;95:925–929
  5. Wong ND, Levy D, Kannel WB. Prognostic significance of the electrocardiogram after Q wave myocardial infarction (The Framingham Study). Circulation. 1990;81:780–789
  6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)). J Am Coll Cardiol. 2004;44:671–719
  7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  8. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–199
  9. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–2353
  10. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–2733
  11. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333:1091–1094
  12. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892–1900
  13. Zipes DP, Braunwald E. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th edn.. Philadelphia, PA: Elsevier Saunders; 2005;
  14. Bar FW, Volders PG, Hoppener P, et al. Development of ST-segment elevation and Q- and R- wave changes in acute myocardial infarction and the influence of thrombolytic therapy. Am J Cardiol. 1996;77:337–343
  15. Andrews J, French JK, Manda SO, White HD. New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction. Eur Heart J. 2000;21:647–653
  16. Birnbaum Y, Chetrit A, Sclarovsky S, et al. Abnormal Q waves on the admission electrocardiogram of patients with first acute myocardial infarction: prognostic implications. Clin Cardiol. 1997;20:477–481
  17. Wong CK, Gao W, Raffel OC, et al. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet. 2006;367:2061–2067
  18. Goodman SG, Langer A, Ross AM, et al. GUSTO-I Angiographic Investigators Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. Circulation. 1998;97(5):444–450
  19. Goodman SG, Barr A, Langer A, et al. Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era. Am Heart J. 2002;144(2):243–250
  20. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation. 2001;104:2981–2989
  21. Sjoholm A, Nystrom T. Endothelial inflammation in insulin resistance. Lancet. 2005;365:610–612
  22. Morishita E, Asakura H, Jokaji H, et al. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis. 1996;120:7–14
  23. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J. 1995;130:1270–1275
  24. Marso SP, Miller T, Rutherford BD, et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol. 2007;100:206–210

 Funding: This research was supported by an unrestricted grant from Sanofi-Aventis, Paris, France. The Global Registry of Acute Coronary Events is supported by an unrestricted educational grant from Sanofi-Aventis to the Center for Outcomes Research, University of Massachusetts Medical School. Sanofi-Aventis had no involvement in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The design, conduction, and interpretation were undertaken by an independent steering committee.

 Conflict of Interest: There are no other conflicts of interest for any of the authors.

 Authorship: All authors meet criteria for authorship including access to the data and all authors had a role in the writing of the manuscript.

PII: S0002-9343(08)00980-7

doi: 10.1016/j.amjmed.2008.08.029

The American Journal of Medicine
Volume 122, Issue 2 , Pages 144-151 , February 2009

Article Tools

* Image Usage & Resolution